Oncogenic kinase signalling (original) (raw)

• Hunter, T. Signaling - 2000 and beyond. Cell 100, 113–127 (2000).
  Article CAS PubMed Google Scholar
• Pawson, T. & Nash, P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027–1047 (2000).
  CAS PubMed Google Scholar
• Reed, J. C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17, 2941–2953 (1999).
  Article CAS PubMed Google Scholar
• Hunter, T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Phil. Trans. R. Soc. Lond. B 353, 583–605 (1998).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Plowman, G. D., Sudarsanam, S., Bingham, J., Whyte, D. & Hunter, T. The protein kinases of Caenorhabditis elegans: a model for signal transduction in multicellular organisms. Proc. Natl Acad. Sci. USA 96, 13603–13610 (1999).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Robinson, D. R., Wu, Y. M. & Lin, S. F. The protein tyrosine kinase family of the human genome. Oncogene 19, 5548–5557 (2000).
  Article CAS PubMed Google Scholar
• Futreal, P. A. et al. Cancer and genomics. Nature 409, 850–852 (2001).
  Article ADS CAS PubMed Google Scholar
• Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211–225 (2000).
  Article CAS PubMed Google Scholar
• Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).
• Heldin, C.-H. Dimerization of cell surface receptors in signal transduction. Cell 80, 213–223 (1995).
  Article CAS PubMed Google Scholar
• Hubbard, S. R. & Till, J. H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373–398 (2000).
  Article CAS PubMed Google Scholar
• Hubbard, S. R., Mohammadi, M. & Schlessinger, J. Autoregulatory mechanisms in protein-tyrosine kinases. J. Biol. Chem. 273, 11987–11990 (1998).
  Article CAS PubMed Google Scholar
• Jiang, G. & Hunter, T. Receptor signaling: when dimerization is not enough. Curr. Biol. 9, R568–R571 (1999).
  Article CAS PubMed Google Scholar
• Shewchuk, L. M. et al. Structure of the Tie2 RTK domain. Self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure Fold. Des. 8, 1105–1113 (2000).
  Article CAS PubMed Google Scholar
• Binns, K. L., Taylor, P. P., Sicheri, F., Pawson, T. & Holland, S. J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 20, 4791–4805 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Irusta, P. M. & DiMaio, D. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation. EMBO J. 17, 6912–6923 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hirota, S. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577–580 (1998).
  Article ADS CAS PubMed Google Scholar
• Meshinchi, S. et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 97, 89–94 (2001).
  Article CAS PubMed Google Scholar
• Harari, D. & Yarden, Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 19, 6102–6114 (2000).
  Article CAS PubMed Google Scholar
• Jhiang, S. M. The RET proto-oncogene in human cancers. Oncogene 19, 5590–5597 (2000).
  Article CAS PubMed Google Scholar
• Santoro, M. et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267, 381–383 (1995).
  Article ADS CAS PubMed Google Scholar
• Zhou, S. et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373, 536–539 (1995).
  Article Google Scholar
• Bocciardi, R. et al. The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. Oncogene 15, 2257–2265 (1997).
  Article CAS PubMed Google Scholar
• Murakami, H. et al. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation. Biochem. Biophys. Res. Commun. 262, 68–75 (1999).
  Article CAS PubMed Google Scholar
• Smith-Hicks, C. L., Sizer, K. C., Powers, J. F., Tischler, A. S. & Costantini, F. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J. 19, 612–622 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• van Weering, D. H. & Bos, J. L. Signal transduction by the receptor tyrosine kinase Ret. Recent Results Cancer Res. 154, 271–281 (1998).
  Article CAS PubMed Google Scholar
• Ashman, L. K. The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell Biol. 31, 1037–1051 (1999).
  Article CAS PubMed Google Scholar
• Besmer, P. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr. Opin. Cell Biol. 3, 939–946 (1991).
  Article CAS PubMed Google Scholar
• Blume-Jensen, P. & Hunter, T. in Cancer Research - An Encyclopedic Reference (ed. Schwab, M.) (Springer, in the press).
• Kozlowski, M. et al. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol. Cell. Biol. 18, 2089–2099 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lennartsson, J. et al. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene 18, 5546–5553 (1999).
  Article CAS PubMed Google Scholar
• Taniguchi, M. et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 59, 4297–4300 (1999).
  CAS PubMed Google Scholar
• Schmidt, L. et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet. 16, 68–73 (1997).
  Article CAS PubMed Google Scholar
• Chian, R. et al. PI3 kinase mediates transformation of hematopoietic cells by the V816 c-kit mutant. Exp. Hematol. 28, 1491 (2000).
  Article Google Scholar
• Blume-Jensen, P., Janknecht, R. & Hunter, T. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr. Biol. 8, 779–782 (1998).
  Article CAS PubMed Google Scholar
• Chen, H. E., Chang, S., Trub, T. & Neel, B. G. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 16, 3685–3697 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Paulson, R. F., Vesely, S., Siminovitch, K. A. & Bernstein, A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nature Genet. 13, 309–315 (1996).
  Article CAS PubMed Google Scholar
• Piao, X., Paulson, R., van der Geer, P., Pawson, T. & Bernstein, A. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc. Natl Acad. Sci. USA 93, 14665–14669 (1996).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Beghini, A. et al. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum. Mol. Genet. 9, 2297–2304 (2000).
  Article CAS PubMed Google Scholar
• Druker, B. J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2, 561–566 (1996).
  Article CAS PubMed Google Scholar
• Heinrich, M. C. et al. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96, 925–932 (2000).
  Article CAS PubMed Google Scholar
• Stehelin, D., Varmus, H. E., Bishop, J. M. & Vogt, P. K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–173 (1976).
  Article ADS CAS PubMed Google Scholar
• Bjorge, J. D., Jakymiw, A. & Fujita, D. J. Selected glimpses into the activation and function of src kinase. Oncogene 19, 5620–5635 (2000).
  Article CAS PubMed Google Scholar
• Sicheri, F. & Kuriyan, J. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7, 777–785 (1997).
  Article CAS PubMed Google Scholar
• Irby, R. B. et al. Activating SRC mutation in a subset of advanced human colon cancers. Nature Genet. 21, 187–190 (1999).
  Article CAS PubMed Google Scholar
• Nowell, P. & Hungerford, D. A minute chromosome in human chronic granulocytic leukemia. Science 132, 1497 (1960).
  Google Scholar
• Vigneri, P. & Wang, J. Y. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nature Med. 7, 228–234 (2001).
  Article CAS PubMed Google Scholar
• Wang, J. Y. Regulation of cell death by the abl tyrosine kinase. Oncogene 19, 5643–5650 (2000).
  Article CAS PubMed Google Scholar
• Stiewe, T. & Putzer, B. M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nature Genet. 26, 464–469 (2000).
  Article CAS PubMed Google Scholar
• Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A. & Pendergast, A. M. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13, 2400–2411 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• McWhirter, J. R., Galasso, D. L. & Wang, J. Y. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13, 7587–7595 (1993).
  CAS PubMed PubMed Central Google Scholar
• Deininger, M. W., Goldman, J. M. & Melo, J. V. The molecular biology of chronic myeloid leukemia. Blood 96, 3343–3356 (2000).
  Article CAS PubMed Google Scholar
• Hallek, M. et al. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells. Br. J. Haematol. 94, 5–16 (1996).
  Article CAS PubMed Google Scholar
• Gesbert, F., Sellers, W. R., Signoretti, S., Loda, M. & Griffin, J. D. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway. J. Biol. Chem. 275, 39223–39230 (2000).
  Article CAS PubMed Google Scholar
• Skorski, T. et al. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J. 16, 6151–6161 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Horita, M. et al. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J. Exp. Med. 191, 977–984 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ihle, J. N., Nosaka, T., Thierfelder, W., Quelle, F. W. & Shimoda, K. Jaks and Stats in cytokine signaling. Stem Cells 15(Suppl. 1), 105–111; discussion, 112 (1997).
  Article CAS PubMed Google Scholar
• Darnell, J. E. STATs and gene regulation. Science 277, 1630–1635 (1997).
  Article ADS CAS PubMed Google Scholar
• Bromberg, J. F. Activation of STAT proteins and growth control. BioEssays 23, 161–169 (2001).
  Article CAS PubMed Google Scholar
• Bowman, T., Garcia, R., Turkson, J. & Jove, R. STATs in oncogenesis. Oncogene 19, 2474–2488 (2000).
  Article CAS PubMed Google Scholar
• Haspel, R. L. & Darnell, J. E. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. Proc. Natl Acad. Sci. USA 96, 10188–10193 (1999).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Yasukawa, H., Sasaki, A. & Yoshimura, A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18, 143–164 (2000).
  Article CAS PubMed Google Scholar
• Peeters, P. et al. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90, 2535–2540 (1997).
  Article CAS PubMed Google Scholar
• Lacronique, V. et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309–1312 (1997).
  Article ADS CAS PubMed Google Scholar
• Schwaller, J. et al. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 6, 693–704 (2000).
  Article CAS PubMed Google Scholar
• Rosa Santos, S. C., Dumon, S., Mayeux, P., Gisselbrecht, S. & Gouilleux, F. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene 19, 1164–1172 (2000).
  Article CAS PubMed Google Scholar
• Migone, T. S. et al. Functional cooperation of the interleukin-2 receptor beta chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation. Mol. Cell. Biol. 18, 6416–6422 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Pfeffer, L. M. et al. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276, 1418–1420 (1997).
  Article CAS PubMed Google Scholar
• Vanhaesebroeck, B. & Alessi, D. R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346(3), 561–576 (2000).
  Article Google Scholar
• Schmelzle, T. & Hall, M. N. TOR, a central controller of cell growth. Cell 103, 253–262 (2000).
  Article CAS PubMed Google Scholar
• Pyronnet, S. & Sonenberg, N. Cell-cycle-dependent translational control. Curr. Opin. Gen. Dev. 11, 13–18 (2001).
  Article CAS Google Scholar
• Dufner, A. & Thomas, G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100–109 (1999).
  Article CAS PubMed Google Scholar
• Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).
• Bellacosa, A. et al. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene 8, 745–754 (1993).
  CAS PubMed Google Scholar
• Toker, A. & Newton, A. C. Cellular signaling: pivoting around PDK-1. Cell 103, 185–188 (2000).
  Article CAS PubMed Google Scholar
• Meier, R. & Hemmings, B. A. Regulation of protein kinase B. J. Recept. Signal. Transduct. Res. 19, 121–128 (1999).
  Article CAS PubMed Google Scholar
• Williams, M. R. et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439–448 (2000).
  Article CAS PubMed Google Scholar
• Datta, S. R., Brunet, A. & Greenberg, M. E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905–2927 (1999).
  Article CAS PubMed Google Scholar
• Diehl, J. A., Cheng, M., Roussel, M. F. & Sherr, C. J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499–3511 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, B. P. et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biol. 3, 245–252 (2001).
  Article CAS PubMed Google Scholar
• Chang, H. W. et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276, 1848–1850 (1997).
  Article CAS PubMed Google Scholar
• Shayesteh, L. et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genet. 21, 99–102 (1999).
  Article CAS PubMed Google Scholar
• Jimenez, C. et al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 17, 743–753 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P. P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genet. 27, 222–224 (2001).
  Article CAS PubMed Google Scholar
• Sasaki, T. et al. Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ. Nature 406, 897–902 (2000).
  Article ADS CAS PubMed Google Scholar
• Brennan, P., Babbage, J. W., Thomas, G. & Cantrell, D. p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. Mol. Cell. Biol. 19, 4729–4738 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Feng, L. X., Ravindranath, N. & Dym, M. Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia. J. Biol. Chem. 275, 25572–25576 (2000).
  Article CAS PubMed Google Scholar
• Masahiro, A., Blazek, E. & Vogt, P. K. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc. Natl Acad. Sci. USA 98, 136–141 (2001).
  Article ADS Google Scholar
• Cichowski, K. & Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593–604 (2001).
  Article CAS PubMed Google Scholar
• Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR-Abl tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031–1037 (2001).
  Article CAS PubMed Google Scholar
• Druker, B. J. et al. Activity of a specific inhibitor of the BCR-Abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038–1042 (2001).
  Article CAS PubMed Google Scholar
• Joensuu, H. et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 344, 1052–1056 (2001).
  Article CAS PubMed Google Scholar